
Quotient Limited QTNT
Quartalsbericht 2023-Q3
hinzugefügt 23.05.2026
Quotient Limited Kurzfristige Verbindlichkeiten 2011-2026 | QTNT
Kurzfristige Verbindlichkeiten Jährlich Quotient Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.8 M | 59.5 M | 50.4 M | 25.4 M | 27.1 M | 29.7 M | 21.4 M | 54.8 M | 12.9 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 59.5 M | 12.9 M | 34.9 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
1.71 B | $ 115.9 | 0.73 % | $ 35.2 B | ||
|
Celcuity
CELC
|
44.2 M | $ 133.57 | -0.51 % | $ 6.25 B | ||
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
3.54 M | $ 7.59 | -16.68 % | $ 10.1 M | ||
|
Castle Biosciences
CSTL
|
68.7 M | $ 20.94 | 6.35 % | $ 607 M | ||
|
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
31.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
85 M | $ 17.68 | 0.03 % | $ 544 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
Guardant Health
GH
|
303 M | $ 125.25 | 4.51 % | $ 15.7 B | ||
|
CareDx, Inc
CDNA
|
89.8 M | $ 22.05 | 2.37 % | $ 1.17 B | ||
|
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
5.1 M | $ 1.8 | - | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 117.6 | 3.29 % | $ 9.7 B | ||
|
Illumina
ILMN
|
1.55 B | $ 151.1 | 4.05 % | $ 24 B | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
333 M | $ 99.53 | -0.53 % | $ 6.72 B | ||
|
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
1.2 B | $ 1 093.48 | -0.71 % | $ 22.5 B | ||
|
Charles River Laboratories International
CRL
|
1.12 B | $ 163.66 | 4.54 % | $ 8.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
NeoGenomics
NEO
|
88.3 M | $ 9.52 | 2.7 % | $ 1.22 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
1.34 B | $ 430.27 | 0.27 % | $ 12.4 B | ||
|
National Research Corporation
NRC
|
36.6 M | $ 19.04 | - | $ 426 M | ||
|
Natera
NTRA
|
310 M | $ 203.17 | 1.12 % | $ 20 B | ||
|
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
134 M | $ 3.91 | 1.56 % | $ 362 M | ||
|
Personalis
PSNL
|
39.6 M | $ 9.35 | 4.53 % | $ 834 M | ||
|
Senseonics Holdings
SENS
|
24.3 M | $ 6.27 | -2.49 % | $ 262 M | ||
|
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.38 | -3.64 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
91.4 M | $ 64.96 | 0.14 % | $ 3.89 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 259.0 | 0.23 % | $ 21.5 B | ||
|
Thermo Fisher Scientific
TMO
|
15.2 B | $ 452.36 | 0.92 % | $ 171 B | ||
|
Waters Corporation
WAT
|
1.24 B | $ 343.25 | 1.35 % | $ 20.4 B | ||
|
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
174 M | $ 9.27 | 1.42 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 194.63 | 0.89 % | $ 21.6 B |